ArticleThe International journal on drug policy2025

Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.

Roman Ivasiy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.